Arcutis Biotherapeutics's chart data is dated 2026-10-07. There is no active technical signal. There are 2 published signal records.
Arcutis Biotherapeutics last closed at $24.17 (+1.05%) on 2026-10-07. Listed on Nasdaq. Trailing 12 months PER is 115.2×. Its overall grade ranks 221 of 737 stocks in Healthcare.
About this company
Arcutis Biotherapeutics last closed at $24.17 (+1.05%) on 2026-10-07. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 221/737
Valuation grade F
Related stocks
- OrganonCustomer
Arcutis의 피부질환 치료제 유통·상업화 파트너
- AstraZenecaCompetitor
면역·염증성 피부질환 및 관련 치료 영역에서 경쟁
- Bausch Health CompaniesCompetitor
피부과 처방의약품 시장에서 경쟁
About Arcutis Biotherapeutics
- What technical signals does Arcutis Biotherapeutics (ARQT) have?
- Arcutis Biotherapeutics current technical signals: no active technical signal.
- Is Arcutis Biotherapeutics a cup-and-handle pattern?
- No. Arcutis Biotherapeutics has no valid Cup signal right now.
- What published figures are available for Arcutis Biotherapeutics?
- Market cap: $2.96B. Trailing 12 months PER: 115.2×. Latest quarter PBR: 14.89×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-08 dataset
Turn what you saw on this name into a strategy
Ask Q about Arcutis Biotherapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.